ICON has extensive experience in conducting gastrointestinal studies

We work across the entire drug development spectrum. Our experience ranges from the initial studies in Phase I through post-marketing efforts in Phase IV.

ICON Gastrointestinal experience in last five years

  • 121

    Studies conducted
  • 34,363

    Patients involved
  • 7,973

    Sites worldwide

Broad disease experience

ICON's Gastrointestinal team comprises dedicated drug development experts with significant experience conducting clinical trials for experimental therapeutics in the following diseases:



Acid Reflux Chronic Functional Constipation Indigestion
Acute Gastric Pain Crohn’s Disease Idiopathic Gastroparesis
Acute Pancreatitis Diarrhea Inflammatory Bowel Disease
Bowel Prep Diverticulitis Irritable Bowel Syndrome
Celiac Dyspepsia Irritable Bowel Syndrome with Constipation
Chronic Constipation Eosinophilic Esophagitis Irritable Bowel Syndrome with Diarrhea
Colorectal Conditions Esophagitis Short Bowel Syndrome
Constipation Gastroesophageal Reflux Traveler's Diarrhea
Chronic Idiopathic Constipation GERD Ulcerative Colitis